Pharmacological profiles of mycophenolate mofetil (CellCpt<SUP>®</SUP>), a new immunosuppressive agent
نویسندگان
چکیده
منابع مشابه
Circadian variation in haematological toxicity of the immunosuppressive agent “Mycophenolate Mofetil” in rats
Because of biological rhythms, drug efficiency and toxicity vary according to the time of administration of the drug. This study investigates whether the haematological toxicity of the immunosuppressive agent Mycophenolate Mofetil varies according to the circadian dosing-time in rats. 300 mg/kg of Mycophenolate Mofetil was injected by i.p. route to different groups of animals at six different c...
متن کاملMycophenolate mofetil--a new atheropreventive drug?
Atherosclerosis is a form of chronic inflammation in which endothelial cell dysfunction, fibroproliferative process, oxidative stress and inflammatory cell activation are linked to plaque development and destabilization. T-lymphocytes also play a key role in pathogenesis of atherosclerosis. As a consequence, the suggested concept that modulation of an immunological response could be an appropri...
متن کاملNew immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
In the past two decades, many new small molecules with immunosuppressive properties have been discovered. These xenobiotic drugs have been particularly developed for clinical use in organ transplantation to prevent allograft rejection. During clinical investigation in transplantation, some of these substances have also been observed to provide therapeutic efficacy in inflammatory skin disorders...
متن کاملIs mycophenolate mofetil a new treatment for pityriasis lichenoides? A case report
Pityriasis lichenoides is an uncommon, acquired, papulosquamous disorder that exhibits various clinical presentations, including acute, chronic, and febrile ulceronecrotic Mucha- abermann forms. Pityriasis lichenoides chronica (PLC) is the chronic form of this continuum. Its treatment is challenging for patients and clinicians and some cases are multidrug resistant. Today, this disorder has man...
متن کاملIn vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil.
The immunosuppressive drug mycophenolate mofetil (MMF) is used to prevent organ rejection after transplantation and has shown some efficacy to prevent the fibrotic complications that occur during autoimmune diseases such as systemic sclerosis or during graft-versus-host disease (GVHD). We tested the hypothesis that MMF may exert direct effects on fibroblast extracellular matrix remodeling. Incu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Folia Pharmacologica Japonica
سال: 2001
ISSN: 0015-5691,1347-8397
DOI: 10.1254/fpj.117.131